Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Canaery is builds a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds.
Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.
Theator is a surgical intelligence platform that combines artificial intelligence and computer vision to improve surgeon performance.
Hi Fidelity Genetics is a start up based in Durham, NC.
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.
SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies
Wearable technology to predict and prevent sepsis.
Visla Labs is an AI medical diagnostics platform.
KdT Ventures has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
KdT Ventures's top investment sectors include Biotechnology, Artificial Intelligence (AI), Health Care, Information Technology, Software. The firm invests across 21 different industry categories.
Among tracked funding rounds, Parthenon Therapeutics received $65.0M in a Series A round. KdT Ventures's total known invested capital is $718.5M.
KdT Ventures's average investment size is $18.0M across its portfolio of 57 companies.
Recent KdT Ventures portfolio additions include Canaery, Checkerspot, Theator, Hi Fidelity Genetics, Parthenon Therapeutics. These companies were founded in 2020 or later.